Omniseq

Omniseq

Omniseq is a Buffalo, New York-based diagnostic company developing molecular sequencing and immune profiling for cancer diagnostics.

OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory based in Buffalo, New York. The company is making significant investments to create better diagnostics for immuno-oncology therapy selection.

Timeline

2019
Omniseq raises a $1,600,000 venture round.
2017
Omniseq raises a $10,000,000 series B round from LabCorp.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Omniseq Series B round, 2017
10,000,000
2017
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
OmniSeq
January 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.